UX007-CL202: An Open-LabelLong-Term Safety and Efficacy Extension Study in Subjects with Long-Chain Fatty AcidOxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies

Project: Research project

Project Details

StatusActive
Effective start/end date6/16/158/31/50

Funding

  • Ultragenyx Pharmaceutical Inc.